- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01534429
Quantitative Sensory Testing and Analysis of Post Inguinal Hernia Surgery Pain
July 7, 2016 updated by: University of California, Los Angeles
Quantitative Sensory Testing and Neurophysiologic Analysis of Post-Herniorraphy Pain in Patients Undergoing Selective Neurectomy and Mesh Removal
Increasing experience has identified post-herniorraphy chronic pain as an under-recognized and important complication.
Nerve entrapment and injury are recognized as causes of such pain.
Operative treatment for selected patients with this condition includes surgical exploration of the affected groin, identification and removal of involved nerves, and removal of meshoma.
This procedure has been highly effective in treatment of chronic pain.
This study will attempt to subjectively and objectively evaluate the patient's chronic groin pain using quantitative sensory testing (QST) and validated pain scales and questionnaires.
Quantitative sensory testing is a method used to assess damage to the small and large nerve fibers.
It is used to diagnose and assess the severity of nerve damage, and can also help to determine if a neuropathy is responding to treatment.
QST uses a computer testing system to measure how nerves react to vibration and changes in temperature.
The procedure is non-invasive and the patient will feel minimal to no discomfort during testing.
The hypothesis is that any decrease in subjective pain scores would be accompanied by improved QST results.
Study Overview
Detailed Description
Background: Chronic postherniorrhaphy inguinal pain is a complex, major health problem.
In the absence of recurrence or meshoma, laparoscopic retroperitoneal triple neurectomy has emerged as an effective surgical treatment of postherniorrhaphy inguinal pain.
Methods: This prospective pilot study evaluated the neurophysiological and clinical effects of laparoscopic retroperitoneal triple neurectomy.
Ten consecutive adult with chronic postherniorrhaphy inguinal pain and unilateral predominantly neuropathic inguinodynia underwent three comprehensive quantitative sensory testing assessments (preoperative, immediate postoperative, and late postoperative).
Pain severity, health-related function, and sleep quality were assessed over the course of a 6-month follow-up period.
Study Type
Observational
Enrollment (Actual)
10
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90095
- UCLA Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with chronic pain occuring after groin hernia repair who are surgical candidates for mesh removal and triple neurectomy.
Description
Inclusion Criteria:
- patient with chronic groin pain after inguinal hernia surgery and are candidates for triple neurectomy with mesh removal
Exclusion Criteria:
- non-English speaking patients
- significant psychiatric or medical disease
- bilateral groin pain
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
chronic post-herniorraphy pain
patients with severe chronic post-herniorraphy pain
|
Quantitative Sensory Testing and Neurophysiologic Testing to be done Pre-operatively and at 3 and 6 months post-operatively.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
changes in quantitative sensory testing and neurophysiologic testing pre-operatively, and at 3-month and 6-month intervals post-operatively
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
changes in Visual Nociceptive Pain Scores, McGill Pain Questionnaire, Activity Assessment Scale, and SF-36 scale pre-operatively and 3-month, 6-month, and 9-months post-operatively
Time Frame: 9 months
|
9 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Andrea L Nicol, M.D., University of California, Los Angeles
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Primary Completion (ACTUAL)
January 1, 2016
Study Completion (ACTUAL)
June 1, 2016
Study Registration Dates
First Submitted
February 13, 2012
First Submitted That Met QC Criteria
February 13, 2012
First Posted (ESTIMATE)
February 16, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
July 11, 2016
Last Update Submitted That Met QC Criteria
July 7, 2016
Last Verified
July 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11-000180
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hernia
-
Muhammet Mustafa VuralRecruitingInguinal Hernia | Femoral Hernia | Obturator HerniaTurkey
-
University of California, DavisNot yet recruitingInguinal Hernia | Hernia | Hiatal Hernia | Ventral Hernia | Diastasis Recti | Hernia Abdominal WallUnited States
-
University of NebraskaLifeCellCompletedHiatal Hernia | Esophageal Hernia | Hernia, Esophageal | Hernia, Paraesophageal | Paraesophageal Hiatal Hernia | Sliding Esophageal Hernia | Sliding Hiatal HerniaUnited States
-
Mette Astrup MadsenCompletedInguinal Hernia | Femoral HerniaDenmark
-
Medtronic - MITGCompletedInguinal Hernia | Ventral HerniaUnited States
-
Advanced Medical Solutions Ltd.CompletedInguinal Hernia | Hernia | Femoral Hernia | Groin HerniaUnited States
-
The Cleveland ClinicJoseph and Florence Mandel Family FoundationRecruitingHernia | Hernia Surgery | Hernia Incisional | Hernia Incisional Ventral | Hernia Abdominal Wall | Hernia Repair With Compartment Syndrome | Botox InjectionUnited States
-
Hobart HarrisWithdrawnHernia | Ventral Hernia | Abdominal Hernia
-
GSVM Medical CollegeCompleted
-
Konya Meram State HospitalCompletedInguinal Hernia | Ventral Hernia | General SurgeryTurkey
Clinical Trials on Quantitative Sensory Testing
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
University Hospital, BrestCompletedSensitive SkinFrance
-
Julia FinkelCompletedSCD With Severe Phenotype (HbSS, HbSβ0 Thalassemia, HbSOARab)United States
-
University GhentRecruiting
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Walton Centre NHS Foundation TrustActive, not recruitingFacial PainUnited Kingdom
-
Spine Centre of Southern DenmarkUniversity of Southern DenmarkCompleted
-
University of Sao PauloCompletedNeuralgia | Facial Pain | Comorbidity
-
Region Örebro CountyAalborg UniversityCompleted